FDA Discloses New E. Coli Romaine Outbreak After It Ends

  • Published | 13 November 2019

CR claims that perhaps the organization has been waiting longer to notify consumers

Global: On 1 November, the Food and Drug Administration announced an E. coli outbreak. From 12 July to 8 September, coli (O157:H7) infections associated with romaine lettuce sickened at least 23 people across 12 states.  This E coli strain generates a toxin that can cause serious disease kidney failure and death in several cases. As a result of the infection, of both the victims were infected in this latest outbreak, and no deaths were reported. The announcement came more than a month after the review of the cluster of cases started by the Centers for Disease Control and Prevention. In three separate outbreaks of E. coli, romaine lettuce was implicated. In the last two years, E. coli (O157:H7); one in December 2017, one in spring 2018, and one in fall 2018. The spring 2018 outbreak was the largest and deadliest E. Coli decades of coli outbreak in the U.S. The E. coli engaged in the latest epidemic was the same extreme pathogenic form as that of the two major E. Coli in 2018, there used to be coli outbreaks.

According to BlueWeave Consulting, the most common way to obtain an E. coli is infected meat, contaminated water, and personal contact. Infection with the E. coli bacteria in general, when slaughtering and processing of cattle, E. Coli bacteria can get on the meat in their intestines. Ground beef combines meat from many different bovine animals, which increases the risk of contamination. Furthermore, human and animal feces, including streams, rivers, lakes and water used to irrigate crops, can pollute ground and surface water. Despite the use of chlorine, ultraviolet light or ozone in public water systems to kill E. Coli, some outbreaks were correlated with municipal water supplies contaminated. All the factors in collaboration expected to boost the growth of the E. coli testing in various industry in the upcoming years.

According to BlueWeave Consulting report titled “E. Coli Testing Market (Testing - Clinical, and Environmental; End Users - Diagnostic Laboratories, Hospitals, Bottled Water Suppliers, Home & Drinking Water Suppliers, Government Agencies, Waste Water Treatment Agencies and Others End Users), By Region (North America, Europe, Asia Pacific, Middle East & Africa and Latin America); Size and Forecast, 2018-2025

The global E. coli testing market is estimated to grow at a significant rate, during the forecast period 2018-2025. Increasing incidences of diarrhea and anti-biotic Resistance of E. Coli Testing by PCR Tests are the key factor anticipated to drive the growth of E. coli testing in the global market during the forecast period of 2019-2025. In addition, increasing incidence of diarrhea and high demand for accurate diagnostic technology are the major factors that drive the growth of the global E. coli testing market. The technological testing advancement in hospitals and specialty clinics boosting the global market in upcoming years with commendable growth rate.